Moreover, we demonstrated that NFAT1 is activated not only in vivo but also long term cultured glioma cell lines, suggesting that activation of NFAT1 may not be affected by tumor microenvironment and is an inherent characteristic of GBM. Here, NFATC2 is linked to central nervous system cancer.